JOYN Advisors’s Tvardi Therapeutics TVRD Stock Holding History

JOYN Advisors’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3	Closed	-$2K	–	1891
2018 Q3	$2K	Buy	+3	New	+$2.17K	﹤0.01%	1509

Other funds holding TVRD

RCP

Rho Capital Partners New York $20.4M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JOYN Advisors's TVRD Position: Q4 2018 in Review

JOYN Advisors sold out of Tvardi Therapeutics (TVRD) in Q4 2018, closing a stake of 3 shares — an estimated $2K sold.

JOYN Advisors first reported a position in TVRD in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 134 funds tracked by Wall St. Rank hold TVRD as of Q4 2018.

JOYN Advisors reported no remaining Tvardi Therapeutics position as of Q4 2018 after selling out during the quarter.
JOYN Advisors sold 3 Tvardi Therapeutics shares in Q4 2018, an estimated $2K.
JOYN Advisors first reported a position in Tvardi Therapeutics in Q3 2018 and held it in 1 quarter.
JOYN Advisors's Tvardi Therapeutics position peaked at $2K in Q3 2018.
134 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2018.

Based on JOYN Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.